Author: CSN
Medical marijuana reclassified as less dangerous drug. Pot stocks take a breather.
The Trump administration also announced the beginning of an expedited administrative hearing process to consider the rescheduling marijuana more broadly.
What the Trump administration’s move to reclassify marijuana means for investors
The Department of Justice said it will immediately move FDA-approved marijuana from Schedule I to Schedule III under the Controlled…
Cannabis Stocks Soared—Than Sank. Here’s What Investors Need to Know.
Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug…
US to loosen marijuana rules in major shift for $47 billion industry
The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly…
Trump administration moves to reclassify cannabis in major shift that could expand research
Trump administration to reclassify marijuana as Schedule III, easing research barriers but not legalizing the drug or changing current federal…
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news…
How does marijuana rescheduling affect cannabis companies now?
Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
Cannabis MSOs to see increased investment, lower taxes from reclassification
Marijuana’s Schedule III shift could boost cannabis MSOs via new capital access and Section 280E tax relief. Read more here.
US reduces marijuana restrictions in lift to ailing industry
The US Justice Department reclassified state-regulated marijuana as a less dangerous drug, a major shift that could increase legal cannabis…
Instant View: Cannabis rescheduling fuels optimism across industry
Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of reclassifying the drug as…
Recent Comments